Sedative-hypnotic drugs such as diazepam (a benzodiazepine) can impose graded effects on the function of the central nervous system (CNS), resulting in a spectrum of clinical actions. This range of therapeutic actions progresses from sedation at low doses, to induction of anesthesia at significantly higher doses. BZs act at nanomolar concentrations to modulate chloride ion flux through GABA A -receptor channels, thereby affecting synaptic transmission 1-3 . The crucial amino acids responsible for this potent action of BZs in part have been determined, and are located within the N-terminal domains of α and γ subunits [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The importance of two α subunit isoforms (α 1 or α 2 ) in mediating sedative or anxiolytic action of diazepam, respectively, has been demonstrated using transgenic animals [17] [18] [19] [20] .
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Sedative-hypnotic drugs such as diazepam (a benzodiazepine) can impose graded effects on the function of the central nervous system (CNS), resulting in a spectrum of clinical actions. This range of therapeutic actions progresses from sedation at low doses, to induction of anesthesia at significantly higher doses. BZs act at nanomolar concentrations to modulate chloride ion flux through GABA A -receptor channels, thereby affecting synaptic transmission [1] [2] [3] . The crucial amino acids responsible for this potent action of BZs in part have been determined, and are located within the N-terminal domains of α and γ subunits [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The importance of two α subunit isoforms (α 1 or α 2 ) in mediating sedative or anxiolytic action of diazepam, respectively, has been demonstrated using transgenic animals [17] [18] [19] [20] .
Certain BZs such as diazepam, midazolam and lorazepam are also known for their anesthetic properties 21 and are routinely used in surgical procedures. However, in comparison to the extensive studies on the high-affinity action of BZs, little is known about the molecular determinants of the anesthetic action of BZs.
In this study, we have demonstrated that diazepam, in the presence of low GABA concentrations, produces two distinct components of potentiation within the nanomolar (nM) and micromolar (µM) concentration ranges for the α 1 β 2 γ 2 -receptor channel. In contrast to the nM component, the µM component of diazepam action is independent of the γ 2 subunit and is insensitive to the selective BZ antagonist flumazenil. Mutations at equivalent residues within the TM 2 of α, β and γ subunits, proven important for the action of other anesthetics, nullify the µM component without significantly affecting the nM component of response to diazepam. Furthermore, the µM action of diazepam can also be conferred upon the BZ-insensitive ρ 1 -receptor channel by converse mutation of the corresponding TM 2 residue and a TM 3 residue. The physiological significance of the µM action of diazepam is discussed in the light of the dynamics of benzodiazepine concentrations, the persistence of low concentrations of GABA and the tonic level of GABA A receptor activity within the CNS. potentiation was diminished significantly at EC 8 GABA, and eventually abolished at EC 16 GABA.
Monophasic potentiation of α 1 β 2 by diazepam
Co-expression of cRNA for α 1 and β 2 subunits also yielded GABAgated receptor channels. The α 1 β 2 -receptor channel can be distinguished from the α 1 β 2 γ 2 -receptor channel due to α 1 β 2 's unique pharmacological and kinetic characteristics. For example, the α 1 β 2 -receptor channel is more sensitive to GABA in comparison to the α 1 β 2 γ 2 -receptor channel ( Table 1) . Figure 1c and d shows the diazepam concentration-response relationship (10 to 150,000 nM) at EC 3 GABA for the α 1 β 2 -receptor channel. Diazepam elicited only a single component of potentiation within the µM concentration range for the α 1 β 2 -receptor channel, increasing the control EC 3 GABA currents by more than twelve-fold ( Fig. 1c and d) . Furthermore, the EC 50 and the Hill coefficient values for the µM component of diazepam action were similar for both α 1 β 2 and α 1 β 2 γ 2 -receptor channels (at EC 3 GABA, Table 1 ). The lack of α 1 β 2 -receptor channel sensitivity to diazepam within the nM concentration range has been documented previously, as the presence of the γ subunit is essential in conferring diazepam's nM action 11 .
Zn 2+ does not block the µM action of diazepam Zinc inhibits the GABA-evoked currents from α 1 β 2 -but not from α 1 β 2 γ 2 -receptor channels 23, 24 (Fig. 2) . Zinc exhibited properties of an open channel blocker for α 1 β 2 , inhibiting the GABA-evoked currents back to the baseline. In comparison, the GABA currents for α 1 β 2 γ 2 -receptor channels were reduced to 64 ± 4% of the control in the presence of 10 µM Zn 2+ , suggesting that a fraction of the total GABA current may have arisen from α 1 β 2 -type-receptor channels. To confirm that the µM potentiation of α 1 β 2 γ 2 at EC 3 GABA was not due to the presence of α 1 β 2 -receptor channels (see above), the α 1 β 2 γ 2 diazepam concentration-response relationship at EC 3 GABA was determined in the presence of 10 µM Zn 2+ (Fig. 2b) . In these experiments, the characteristics of α 1 β 2 γ 2 's biphasic potentiation by diazepam were unaltered in the presence of Zn 2+ ( Table 1) . For the nM and the µM components, the EC 50 /Hill coefficient values obtained in the presence of Zn 2+ were 0.048 ± 0.003/1.23 ± 0.05 and 60.5 ± 4.7/2.97 ± 0.25, respectively. Moreover, the absolute magnitudes of potentiation for the two components were 3.44 ± 0.26 for the nM and 4.34 ± 0.26 for the µM component of diazepam action. These values are similar to the values determined for the α 1 β 2 γ 2 -receptor channel in the absence of Zn 2+ ( Table 1) . These data indicate that the significant potentiation observed at µM concentration of diazepam for α 1 β 2 γ 2 (at EC 3 GABA) does not arise from the concomitant presence of α 1 β 2 -receptor channels.
The µM action of diazepam is insensitive to flumazenil Flumazenil is a selective antagonist for the high-affinity (nM) comarticles 3.31 ± 0.59. However, the EC 50 and the Hill coefficient values derived for the diazepam µM component in the presence and absence of flumazenil were similar for the α 1 β 2 γ 2 -receptor channel at EC 3 GABA ( Table 1) . Concentrations of flumazenil up to 100 µM were co-applied with 100 µM diazepam (at EC 3 GABA) to test the effect of flumazenil at equivalent concentrations on µM potentiation by diazepam. In the presence of such high concentrations of flumazenil, 100 µM diazepam also produced a significant potentiation (data not shown). These experiments suggest that the nM and µM actions of diazepam are mediated through distinct mechanisms.
TM 2 mutations abolished the µM action of diazepam
The diazepam concentration-response relationships for α S267I β N265I γ S280I at EC 3 , EC 8 and EC 16 GABA were next determined. At all three GABA concentrations tested, diazepam produced only a single component of potentiation within the nM concentration range (Fig. 4b) . The EC 50 and Hill coefficient values derived for α S267I β N265I γ S280I (∼32 to 55 nM and 1.1 to 0.8 nM, respectively; Table 1 ) were similar to the values determined for the nM component of wild-type α 1 β 2 γ 2 ( Table 1) . The α S267I β N265I γ S280I -receptor channel experiments further demonstrate that the nM and the µM actions of diazepam are distinct and separable. In comparison to the α 1 β 2 γ 2 ,-receptor channel, the α S267I β N265I γ S280I -receptor channel exhibited an approximately 40-fold higher sensitivity to GABA ( Table 1) . This difference in articles ponent of BZ action upon the GABA A -receptor channel 25 . For the α 1 β 2 γ 2 -receptor channel at EC 3 GABA, flumazenil at concentrations of 20 µM (or 10 µM, data not shown) abolished the nM, but not the µM, component of diazepam action (Fig. 3) . The overall potentiation at the µM component was reduced from approximately 8 to Imparting diazepam sensitivity to ρ 1 -receptor channels ρ 1 -receptor channels are insensitive to BZs and other intravenous anesthetics 26 (excepting neuroactive steroids 27 ). This property of the homo-oligomeric ρ 1 -receptor channel has been used to study the molecular basis of anesthetic action by conferring anesthetic sensitivity upon ρ 1 . For example, the specific mutation of residue 307 within TM 2 or residue 328 within TM 3 of the ρ 1 subunit (Fig.  5a ) can impart pentobarbital sensitivity upon the ρ 1 -receptor channel 28, 29 . Within the ρ 1 subunit, residues 307 and 328 were substituted, either singly or in combination, to their amino acid counterparts present within the α 1 (Ser, TM 2 ) and β 2 (Met, TM 3 ) subunits. Diazepam did not modulate the GABA-elicited currents at EC 4 in wild-type ρ 1 -, ρ I307S -and ρ W328M -receptor channels (Fig. 5b) . In contrast, doubly mutated ρ 1 became highly sensitive to diazepam ( Fig. 5c and d) . The EC 4 GABA currents for ρ I307S/W328M were markedly potentiated in the presence of diazepam, resulting in an increase of GABA currents up to 9-fold (20 µM diazepam). Figure 5e and f show the potentiation of GABA currents by diazepam (10 µM) at EC 1 , EC 4 , EC 50 and EC 99 GABA for ρ 1 , ρ I307S , ρ W328M and ρ I307S/W328M mutants. For ρ I307S/W328M , diazepam potentiation was most prominent at GABA concentrations below the EC 50 value. The fractional potentiation by diazepam (10 µM) was greatest at low GABA concentrations (EC 1 5.40 ± 0.50 and EC 4 3.20 ± 0.50), whereas at higher GABA concentrations (EC 99 ), little potentiation was observed. In comparison, ρ 1, ρ W328M and ρ I307S did not respond to diazepam at any of the GABA concentrations tested.
The co-application of 20 µM flumazenil and 20 µM diazepam at EC 4 GABA did not significantly alter the diazepam-induced potentiation of the GABA currents elicited from ρ I307S/W328M (data not shown). These data indicate that the µM action of diazepam on ρ I307S/W328M and its nM action on the α 1 β 2 γ 2 -receptor channel are intrinsically different. Diazepam at higher concentrations is an agonist for ρ I307S/W328M (Fig. 6) . The EC 50 value for the direct action of diazepam was 93 ± 1.9 µM associated with a high Hill coefficient (3.3 ± 0.18, Table 1 ). Diazepam was highly efficacious relative to GABA, eliciting a relative maximum current of 0.8. In comparison, wild-type ρ 1 and singly mutated ρ 1 were not directly activated by diazepam at concentrations up to 300 µM.
Differential sensitivity of ρ I307S/W328M to different BZs
The structure-function relationships of different BZs were assessed using the ρ I307S/W328M model. However, at higher concentrations (20 µM and above), flurazepam produced a significant inhibition of the current (Fig.  8) similar to the inhibitory effect observed at equivalent concentrations of diazepam for α S267I β N265I γ S280I (Fig. 4) and wildtype α 1 β 2 γ 2 (between 5 and 20 µM, Fig. 1) . Previous studies have shown that impairing the high-affinity (nM) component of diazepam action within the α 1 β 2 γ 2 by mutation of a single residue within the N-terminal domain of the α subunit causes the µM component to become more prominent 5 . On the other hand, eliminating the diazepam µM component (or its absence in the case of flurazepam) seems to reveal an inhibitory phase (which is otherwise masked by µM concentrations of diazepam; Figs. 4 and 8, respectively) . The co-existence of an inhibitory phase associated with the nM component, as well as the apparent absence of an inhibitory phase following the abolition of the nM component 5 , suggests a close association between the diazepam inhibitory action and the nM component. BZs can ing GABA currents by approximately 0.5-fold and 3-fold at 5 and 20 µM concentrations, respectively. In contrast, flurazepam at concentrations up to 20 µM did not significantly alter the GABAevoked currents from the ρ I307S/W328M -receptor channel.
At EC 3 GABA, the flurazepam concentration-response relationship was determined for the wild-type α 1 β 2 γ 2 -receptor channel to examine whether flurazepam could also produce a biphasic potentiation of GABA currents similar to that observed for diazepam (Fig. 8) . In contrast to diazepam, flurazepam elicited only a single component of potentiation with an EC 50 of 501 ± 96 nM and a Hill coefficient of 0.89 ± 0.06 (Table 1) . Thus, at µM concentration, flurazepam neither produced a µM component of potentiation for α 1 β 2 γ 2 , nor augmented the GABAevoked current from the ρ I307S/W328M -receptor channel. Diazepam and midazolam, which possess a µM action upon ρ I307S/W328M , are used routinely to induce and maintain anesthesia on their own, but flurazepam is not 21 . 
DISCUSSION
The nM and the µM components of diazepam action within the α 1 β 2 γ 2 -receptor channel have intrinsic differences. First, the nM component of diazepam action depends on the presence of the γ subunit. However, both α 1 β 2 -and α 1 β 2 γ 2 -receptor channels are sensitive to µM concentrations of diazepam. Second, for the α 1 β 2 γ 2 -receptor channel, flumazenil inhibits the nM but not the µM component of potentiation by diazepam. Third, there is a difference of three orders of magnitude in potency between the two components. Fourth, mutation of specific TM 2 residues within the α 1 , β 2 and γ 2 subunits abolishes the µM but not the nM effect of diazepam. Fifth, the action of diazepam in eliciting the µM component of both α 1 β 2 γ 2 and α 1 β 2 receptors appears highly cooperative as inferred from the Hill coefficient. Diazepam's direct action upon the ρ I307S/W328M -receptor channel and pentobarbital's direct action on ρ W328M (ref. 28 ) also have a high Hill coefficient ( Table 1) , whereas the nM component persistently displays a low cooperativity (Hill coefficient ∼1). Sixth, there is a correlation between lipid solubility and the extent of the µM potentiation for the BZs tested. For example, diazepam, which has the highest octanol:buffer partition coefficient 32 among the BZs tested, has the greatest efficacy for the ρ I307S/W328M -receptor channel. In comparison, no such relationship has been shown for the nM component. These differences provide strong evidence that the nM and the µM component of diazepam action are mediated via distinct and separable mechanisms. The aforementioned transmembrane residues (α S267 and β M286 and the equivalent residues within ρ 1 ) are centrally important for a number of anesthetic compounds 28, 29, [33] [34] [35] [36] [37] . Also, mutation of the equivalent residue (β N265 ) within human β 2 or β 3 subunits (to a Ser) of αβγ is sufficient to impair the action of loreclezole, a broad-spectrum anticonvulsant that acts at µM concentrations 38 . It is intriguing that so many structurally diverse and hydrophobic compounds mediate their action through these common residues.
The prevalent activation scheme for GABA A receptors postulates two open states 39 . In this scheme, one open state is derived from receptor channels occupied by a single GABA, whereas the other open state arises from doubly bound receptor channel. Diazepam activation of the ρ I307S/W328M -receptor channel appears to be highly cooperative (high Hill coefficient, Table 1 ). (c) Diazepam was highly effective relative to GABA (current magnitude at 300 µM diazepam divided by current magnitude at 10 µM GABA; EC 50 GABA for ρ I307S/W328M , 0.095 ± 0.003 µM) for direct activation of the ρ I307S/W328M -receptor channel. In comparison, diazepam alone, at concentrations up to 300 µM, did not evoke a significant response in either wild-type or singly mutated ρ I .
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From the simple law of mass action, the proportion of the singlybound form of α 1 β 2 γ 2 -receptor channels may predominate at EC 3 and EC 8 GABA. Thus, the µM component of potentiation by diazepam could be the result of selective enhancement of currents from α 1 β 2 γ 2 -receptor channels, which are present in a mono-liganded state. It has been suggested that the incremental CNS effects of benzodiazepines, from sedation to the induction of anesthesia, are all consequences of the relative occupancy of the benzodiazepine nM receptor. We postulate that the more marked actions of benzodiazepine upon the CNS, such as induction of anesthesia, could be the result of its µM action upon GABA A -receptor channels. Three observations suggest this view. First, the nM action of a benzodiazepine such as diazepam is dependent upon the isoform of the α subunit expressed as well as the presence of the γ subunit, and therefore, its nM activity is limited to only certain subtypes of GABA A receptors. On the other hand, diazepam's µM action seems less specific (since both α 1 β 2 -and α 1 β 2 γ 2 -receptor channels are sensitive to µM concentrations of diazepam) and thus may occur at all GABA A receptors. Second, diazepam produces the second component of potentiation only at low concentrations of GABA. Within the CNS, a low extracellular concentration of GABA has been documented 40, 41 . In addition, a tonic level of functional GABA A channel activity in a number of CNS regions has been shown 42, 43 . Third, concentrations of benzodiazepines can reach µM levels within the plasma 44 , and given their high lipid solubility, their concentrations can reach even higher levels within the CNS 45 . Finally, the additional chloride flux due to the µM effect upon GABA A -receptor channels can be predicted to dramatically increase diazepam's overall CNS depressant action. Therefore, under circumstances in which a large dose of diazepam is administered, the marked and ubiquitous action of diazepam at µM concentrations may be central in producing a state of general CNS depression, such as the induction of anesthesia.
METHODS
Oligonucleotide-mediated site-directed mutagenesis was done according to the manufacturer's protocol (Altered Sites, Promega, Madison, Wisconsin). Successful mutagenesis was verified by DNA sequencing. The cDNAs were linearized with HpaI (for ρ 1 ) or SspI (for α 1 ,β 2 , or γ 2 subunits) leaving a 3´ tail several hundred base pairs long. These additional 3´ sequences may increase cRNA stability within the oocyte. The cRNA was transcribed from the linearized cDNAs by standard in vitro transcription procedures (Megascript, Ambion, Austin, Texas).
Xenopus laevis (Xenopus I, Ann Arbor, Michigan) were anesthetized by hypothermia, and oocytes were surgically removed and placed in oocyte Ringer (OR 2 ) that consisted of 82.5 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 1 mM CaCl 2, 1 mM MgCl 2 , 1 mM Na 2 HPO 4 , 50 U/ml penicillin, 50 µg/ml streptomycin, pH 7.5. Oocytes were dispersed and then incubated in OR 2 without Ca 2+ plus 0.3% collagenase A (Boehringer Mannheim, Indianapolis, Indiana) for approximately 1 h. After isolation, the oocytes were thoroughly rinsed with OR 2 , and stage VI oocytes were separated and maintained at 18°C.
Micropipettes for injecting cRNA were made on a Sutter P87 puller (Sutter Instrument Company, Novato, California), and the tips were cut with microscissors. The cRNA in diethylpyrocarbonate-treated water was drawn up into the micropipette with negative pressure and then injected into the oocytes by applying positive pressure using a Picospritzer II (General Valve Corporation, Fairfield, New Jersey). The oocytes were incubated in OR 2 at 18°C for three days before the experiment. To ensure quality and to estimate the quantity of the cRNA, set dilutions of cRNA from mutants were electrophoresed on a 1% formaldehyde-containing agarose gel. The amount of cRNA was judged and matched by interpolation of lanes containing different dilutions of the corresponding cRNA. In addition, for nearly all mutants, two independent isolates were characterized and tested. The α 1 , β 2 and γ 2 subunits were co-injected into Xenopus laevis oocytes in the ratio of 1:1:1.8 to ensure the incorporation of γ 2 subunits.
Three days after injection, oocytes were placed on a mesh machined in a small perfusing volume chamber (∼75 µl), with a t 1/2 and clearance time of approximately 3 and 10 seconds, respectively. The chamber had an inlet in the top and an outlet in the bottom, which allowed continuous and rapid perfusion. Twenty separate reservoirs (100-ml glass containers) were connected to four six-way valves and the outlet of each of these six-way valves (the sixth position was continuous with the reservoir containing the control solution) was connected to one four-way valve. The outlet of the four-way valve led to the chamber. In this way, up to 20 different solutions could be bath-applied to an individual oocyte. Switching between the different solutions was controlled manually. The oocyte was continuously perfused with recording OR 2 (without antibiotics and the 1 mM Na 2 HPO 4 , which was replaced with 1 mM NaCl) and switched to the test solution containing drug.
Recording microelectrodes were made with a Narishige PP-83 puller (Tokyo, Japan) and filled with 3 M KCl. Electrodes with resistances of 0.6-1.6 MΩ were used. A two-electrode voltage-clamp amplifier (Turbo TEC-05 npi, Adams and List, Westbury, New York) was used to record currents in response to the application of drugs. In all cases, membrane potential was clamped to -70 mV. Data were visualized on a Gould TA240 chart recorder (Valley View, Ohio) during the experiment and stored online using Pulse Fit or on a VCR using Instrutech 10b (Port Washington, New York) for subsequent off-line analysis.
The EC 50 and Hill coefficients were estimated by fitting the concentration-response relationships to the Hill equation according to the following formula (Sigma plot, or software provided by D.S. Weiss). I = I max /(1+ [EC 50 /(A)] n ) Alternatively, the data containing two components of potentiation were fitted with a sum of two Hill equations. I = I maxa /(1+ [EC 50a /(A)] n a ) + I maxb /(1+ [EC 50b /(A)] n b ) Here, I is the peak current at a given concentration of agonist A, I max is the maximum current, EC 50 is the concentration of agonist yielding a halfmaximal current, and n is the Hill coefficient.
The fractional potentiation was calculated using the following equation: articles fractional potentiation = (I BZ -I GABA )/I GABA Here, I BZ is the measurement of GABA current in the presence of a given concentration of BZ, and the I GABA is the amplitude of the GABA current alone. In addition, a concentration of 70 nM BZ was bath-applied to the oocytes before collection of BZ data points.
The GABA concentration-response relationships were shifted to lower concentrations (∼two-fold) in oocytes that had high levels of expression. For this reason, oocytes used to collect the data were mostly limited to those that had less than 1 µA in maximal response to GABA. The EC values (for example, EC 4 ) were first determined from the averaged concentrationresponse relationship. The obtained values were then empirically tested for each experiment by comparing the elicited GABA response at this concentration and the maximal response evoked by a GABA concentration equivalent to 20 × EC 50 . The values were then adjusted and retested accordingly until a true EC value was determined. The low EC values (for example, EC 1 ) often had a standard error of 30% relative to expected values.
All BZs were purchased from Sigma, except for diazepam, which was purchased from Sigma or BIOMOL (Plymouth Meeting, Pennsylvania). Stock solutions of BZs at 100 mM were made in DMSO. Test solutions containing drugs were made by adding the BZ stock solutions to rapidly stirred recording OR 2 or OR 2 containing GABA. The presence of the vehicle solution DMSO at the maximum tested concentration (0.2%) did not alter the GABA-induced current from ρ 1 , α 1 β 2 γ 2 or α S267I β N265I γ S280I -receptor channels.
All data presented are the mean ± standard error (s.e.m.).
